Crestwood Advisors Group LLC Iovance Biotherapeutics, Inc. Transaction History

Crestwood Advisors Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$20.35 - $26.63 $162,800 - $213,040	-8,000 Closed	0 $0
Q1 2021 Apr 21, 2021	SELL	$28.67 - $52.59 $71,675 - $131,475	-2,500 Reduced 23.81%	8,000 $253,000
Q4 2019 Feb 12, 2020	BUY	$17.95 - $29.41 $8,975 - $14,705	500 Added 5.0%	10,500 $291,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $24,450 - $61,300	-2,500 Reduced 20.0%	10,000 $245,000
Q3 2017 Nov 20, 2017	BUY	$4.45 - $8.55 $55,625 - $106,875	12,500	12,500 $97,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

Stay updated on Crestwood Advisors Group LLC with notifications on news.